Third Rock Ventures Iii, L.p. - Net Worth and Insider Trading

Third Rock Ventures Iii, L.p. Net Worth

The estimated net worth of Third Rock Ventures Iii, L.p. is at least $184 Million dollars as of 2024-03-29. Third Rock Ventures Iii, L.p. is the 10% Owner of Relay Therapeutics Inc and owns about 7,739,918 shares of Relay Therapeutics Inc (RLAY) stock worth over $64 Million. Third Rock Ventures Iii, L.p. is the 10% Owner of Fulcrum Therapeutics Inc and owns about 5,962,202 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $56 Million. Third Rock Ventures Iii, L.p. is also the 10% Owner of MyoKardia Inc and owns about 221,042 shares of MyoKardia Inc (MYOK) stock worth over $50 Million. Besides these, Third Rock Ventures Iii, L.p. also holds Jounce Therapeutics Inc (JNCE) , Revolution Medicines Inc (RVMD) , Voyager Therapeutics Inc (VYGR) . Details can be seen in Third Rock Ventures Iii, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Third Rock Ventures Iii, L.p. has not made any transactions after 2023-02-01 and currently still holds the listed stock(s).

Transaction Summary of Third Rock Ventures Iii, L.p.

To

Third Rock Ventures Iii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Third Rock Ventures Iii, L.p. owns 12 companies in total, including Revolution Medicines Inc () , Nurix Therapeutics Inc () , and Relay Therapeutics Inc () among others .

Click here to see the complete history of Third Rock Ventures Iii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Third Rock Ventures Iii, L.p.

Ticker Comapny Transaction Date Type of Owner
Revolution Medicines Inc 2022-06-08 10 percent owner
Nurix Therapeutics Inc 2020-07-23 10 percent owner
Relay Therapeutics Inc 2021-01-14 10 percent owner
Pliant Therapeutics Inc 2020-06-02 10 percent owner
Fulcrum Therapeutics Inc 2019-07-22 10 percent owner
Voyager Therapeutics Inc 2023-02-01 10 percent owner
Neon Therapeutics Inc 2018-06-29 10 percent owner
MyoKardia Inc 2018-01-03 10 percent owner
Global Blood Therapeutics Inc 2016-11-14 10 percent owner
Jounce Therapeutics Inc 2021-11-12 10 percent owner
Editas Medicine Inc 2016-02-02 10 percent owner
Decibel Therapeutics Inc 2021-02-11 10 percent owner

Third Rock Ventures Iii, L.p. Latest Holdings Summary

Third Rock Ventures Iii, L.p. currently owns a total of 6 stocks. Among these stocks, Third Rock Ventures Iii, L.p. owns 7,739,918 shares of Relay Therapeutics Inc (RLAY) as of January 14, 2021, with a value of $64 Million and a weighting of 34.98%. Third Rock Ventures Iii, L.p. owns 5,962,202 shares of Fulcrum Therapeutics Inc (FULC) as of July 22, 2019, with a value of $56 Million and a weighting of 30.68%. Third Rock Ventures Iii, L.p. also owns 221,042 shares of MyoKardia Inc (MYOK) as of January 3, 2018, with a value of $50 Million and a weighting of 27.07%. The other 3 stocks Jounce Therapeutics Inc (JNCE) , Revolution Medicines Inc (RVMD) , Voyager Therapeutics Inc (VYGR) have a combined weighting of 7.26% among all his current holdings.

Latest Holdings of Third Rock Ventures Iii, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RLAY Relay Therapeutics Inc 2021-01-14 7,739,918 8.30 64,241,319
FULC Fulcrum Therapeutics Inc 2019-07-22 5,962,202 9.45 56,342,809
MYOK MyoKardia Inc 2018-01-03 221,042 224.91 49,714,556
JNCE Jounce Therapeutics Inc 2021-11-12 4,698,661 1.88 8,833,483
RVMD Revolution Medicines Inc 2022-06-08 129,258 32.20 4,162,108
VYGR Voyager Therapeutics Inc 2023-02-01 36,701 9.29 340,952

Holding Weightings of Third Rock Ventures Iii, L.p.


Third Rock Ventures Iii, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Third Rock Ventures Iii, L.p. has made a total of 1 transactions in Relay Therapeutics Inc (RLAY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Relay Therapeutics Inc is the sale of 5,622,394 shares on January 14, 2021, which brought Third Rock Ventures Iii, L.p. around $227 Million.

According to the SEC Form 4 filings, Third Rock Ventures Iii, L.p. has made a total of 1 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fulcrum Therapeutics Inc is the acquisition of 81,250 shares on July 22, 2019, which cost Third Rock Ventures Iii, L.p. around $1 Million.

According to the SEC Form 4 filings, Third Rock Ventures Iii, L.p. has made a total of 0 transactions in MyoKardia Inc (MYOK) over the past 5 years. The most-recent trade in MyoKardia Inc is the sale of 816,326 shares on January 3, 2018, which brought Third Rock Ventures Iii, L.p. around $34 Million.

More details on Third Rock Ventures Iii, L.p.'s insider transactions can be found in the Insider Trading History of Third Rock Ventures Iii, L.p. table.

Insider Trading History of Third Rock Ventures Iii, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Third Rock Ventures Iii, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Third Rock Ventures Iii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Third Rock Ventures Iii, L.p. is -59.61%. GuruFocus also compares Third Rock Ventures Iii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Third Rock Ventures Iii, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Third Rock Ventures Iii, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Third Rock Ventures Iii, L.p.

Average Relative Return

39.17%

Average relative return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -9.3 -59.61 36.95 39.17 -18.77 -24.02
Relative Return to S&P 500(%) -7.22 -59.98 25.67 29.45 -39.7 -33.9

Third Rock Ventures Iii, L.p. Ownership Network

Ownership Network List of Third Rock Ventures Iii, L.p.

No Data

Ownership Network Relation of Third Rock Ventures Iii, L.p.


Third Rock Ventures Iii, L.p. Owned Company Details

What does Revolution Medicines Inc do?

Who are the key executives at Revolution Medicines Inc?

Third Rock Ventures Iii, L.p. is the 10 percent owner of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include General Counsel Jeff Cislini , See Remarks Margaret A Horn , and Chief Financial Officer Jack Anders .

Revolution Medicines Inc () Insider Trades Summary

Over the past 18 months, Third Rock Ventures Iii, L.p. made no insider transaction in Revolution Medicines Inc (). Other recent insider transactions involving Revolution Medicines Inc () include a net sale of 144,946 shares made by Margaret A Horn , a net sale of 97,493 shares made by Stephen Michael Kelsey , and a net sale of 12,934 shares made by Jeff Cislini .

In summary, during the past 3 months, insiders sold 43,346 shares of Revolution Medicines Inc () in total and bought 0 shares, with a net sale of 43,346 shares. During the past 18 months, 360,837 shares of Revolution Medicines Inc () were sold and 650,000 shares were bought by its insiders, resulting in a net purchase of 289,163 shares.

Revolution Medicines Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Revolution Medicines Inc Insider Transactions

No Available Data

Third Rock Ventures Iii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Third Rock Ventures Iii, L.p.. You might contact Third Rock Ventures Iii, L.p. via mailing address: 29 Newbury Street, 3rd Floor, Boston Ma 02116.

Discussions on Third Rock Ventures Iii, L.p.

No discussions yet.